View in EDS

Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.

Saved in:
Bibliographic Details
Title: Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
Authors: Wang Q; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China. qh_wang@fudan.edu.cn.; Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China. qh_wang@fudan.edu.cn., Jiang F; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China., Xu Y; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China., Lei Y; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China., Zhang L; Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China., Sun X; Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Dec; Vol. 64 (12), pp. 1785-1797. Date of Electronic Publication: 2025 Oct 17.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41107649
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China. qh_wang@fudan.edu.cn.; Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China. qh_wang@fudan.edu.cn.<br /><searchLink fieldCode="AU" term="%22Jiang+F%22">Jiang F</searchLink>; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China.<br /><searchLink fieldCode="AU" term="%22Lei+Y%22">Lei Y</searchLink>; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China.<br /><searchLink fieldCode="AU" term="%22Sun+X%22">Sun X</searchLink>; Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2025 Dec; Vol. 64 (12), pp. 1785-1797. <i>Date of Electronic Publication: </i>2025 Oct 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+part+of+Springer+Science%2BBusiness+Media%22">Adis, part of Springer Science+Business Media </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41107649
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40262-025-01570-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1785
    Titles:
      – TitleFull: Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Jiang F
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Lei Y
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Sun X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1926
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical pharmacokinetics
              Type: main
ResultId 1